SCT-001

N/A

Report date: 2025/02/28 20:00:34

Base Information

Drug NameSCT-001

Drug Alias NameSCT-001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShanghai Gynecologic Oncology Group

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Gynecologic Oncology Group

Inactive CompaniesN/A

Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A